Total Payments
$717.57
2024 Payments
$392.33
Companies
14
Transactions
49
Medicare Patients
2,172
Medicare Billing
$386,529
Payment Breakdown by Category
Food & Beverage$717.57 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $717.57 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $167.51 | 14 | $0 (2024) |
| Lundbeck LLC | $113.22 | 7 | $0 (2024) |
| UCB, Inc. | $83.71 | 5 | $0 (2024) |
| Lilly USA, LLC | $71.29 | 5 | $0 (2024) |
| PFIZER INC. | $66.76 | 4 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $43.81 | 3 | $0 (2023) |
| SK Life Science, Inc. | $39.54 | 2 | $0 (2022) |
| Neurelis, Inc. | $37.96 | 2 | $0 (2024) |
| Aucta Pharmaceuticals, Inc. | $25.40 | 2 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $15.54 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $392.33 | 28 | ABBVIE INC. ($136.67) |
| 2023 | $174.68 | 11 | JAZZ PHARMACEUTICALS INC. ($43.81) |
| 2022 | $138.57 | 9 | Lilly USA, LLC ($39.87) |
| 2021 | $11.99 | 1 | Biohaven Pharmaceuticals, Inc. ($11.99) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Central Nervous System | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: EPILEPSY | ||||||
| 10/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: PAIN | ||||||
| 08/17/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Central Nervous System | ||||||
| 08/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Neurology | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: NEUROLOGY | ||||||
| 06/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: PAIN | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Neurology | ||||||
| 05/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Neuroscience | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Neurology | ||||||
| 02/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,075 | 1,571 | $709,275 | $208,851 |
| 2022 | 14 | 768 | 1,103 | $183,247 | $125,179 |
| 2021 | 10 | 329 | 461 | $70,830 | $52,499 |
Total Patients
2,172
Total Services
3,135
Medicare Billing
$386,529
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 124 | 234 | $162,474 | $40,573 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 370 | $49,236 | $31,854 | 64.7% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 14 | 27 | $123,439 | $21,940 | 17.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 89 | 89 | $21,427 | $13,975 | 65.2% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 91 | 116 | $45,401 | $13,065 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 77 | $23,727 | $11,397 | 48.0% |
| 95713 | Measurement of brain wave activity with video (veeg), 2-12 hours with continuous monitoring | Office | 2023 | 22 | 22 | $102,349 | $11,173 | 10.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 109 | $42,310 | $10,995 | 26.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 28 | 60 | $15,464 | $10,803 | 69.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 155 | $36,847 | $10,378 | 28.2% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 36 | 37 | $47,496 | $7,517 | 15.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 44 | $7,853 | $4,883 | 62.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 36 | 36 | $5,132 | $3,636 | 70.9% |
| 95722 | Measurement of brain wave activity with video (veeg), 37-60 hours with review and report by health care professional | Office | 2023 | 13 | 13 | $4,040 | $2,768 | 68.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 22 | $3,995 | $2,675 | 67.0% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Office | 2023 | 23 | 23 | $4,448 | $2,624 | 59.0% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 35 | 35 | $3,188 | $2,106 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 37 | $3,126 | $2,072 | 66.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,150 | $1,531 | 71.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 26 | $2,665 | $1,097 | 41.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $1,429 | $1,010 | 70.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $1,079 | $778.95 | 72.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 82 | 156 | $45,379 | $27,938 | 61.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 109 | 109 | $25,212 | $15,934 | 63.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 35 | 81 | $19,107 | $15,389 | 80.5% |
About Dr. Jad Donato, M.D
Dr. Jad Donato, M.D is a Neurology healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1356791503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jad Donato, M.D has received a total of $717.57 in payments from pharmaceutical and medical device companies, with $392.33 received in 2024. These payments were reported across 49 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($717.57).
As a Medicare-enrolled provider, Donato has provided services to 2,172 Medicare beneficiaries, totaling 3,135 services with total Medicare billing of $386,529. Data is available for 3 years (2021–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Hackensack, NJ
- Active Since 06/20/2016
- Last Updated 03/06/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1356791503
Products in Payments
- VYEPTI (Biological) $113.22
- UBRELVY (Drug) $96.04
- NURTEC ODT (Drug) $92.37
- Briviact (Drug) $83.71
- EMGALITY (Drug) $71.29
- EPIDIOLEX (Drug) $43.81
- VALTOCO (Drug) $37.96
- QULIPTA (Drug) $37.91
- BOTOX (Biological) $33.56
- Motpoly XR (Drug) $25.40
- Trudhesa (Drug) $15.54
- Austedo XR (Drug) $14.01
- Hizentra (Biological) $13.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hackensack
Dr. Kevin Crutchfield, Md, MD
Neurology — Payments: $20,529
Neurology $20,529
Martin Gizzi, Md, MD
Neurology — Payments: $7,860
Neurology $7,860
Asfi Rafiuddin, D.o, D.O
Neurology — Payments: $5,806
Neurology $5,806
Sweta Goel, Md, MD
Neurology — Payments: $2,866
Neurology $2,866
Dr. Robert Connors, M.d, M.D
Neurology — Payments: $1,140
Neurology $1,140
Dr. Jonathan Tiu, Md, MD
Neurology — Payments: $886.19
Neurology $886.19